Formation of 5α-dihydrotestosterone from 5α-androstane-3α, 17β-diol in prostate cancer LAPC-4 cells – Identifying inhibitors of non-classical pathways producing the most potent androgen. Issue 2 (15th January 2020)
- Record Type:
- Journal Article
- Title:
- Formation of 5α-dihydrotestosterone from 5α-androstane-3α, 17β-diol in prostate cancer LAPC-4 cells – Identifying inhibitors of non-classical pathways producing the most potent androgen. Issue 2 (15th January 2020)
- Main Title:
- Formation of 5α-dihydrotestosterone from 5α-androstane-3α, 17β-diol in prostate cancer LAPC-4 cells – Identifying inhibitors of non-classical pathways producing the most potent androgen
- Authors:
- Boutin, Sophie
Roy, Jenny
Maltais, René
Poirier, Donald - Abstract:
- Graphical abstract: Highlights: [ 14 C]-5α-androstane-3β, 17β-diol (3α-diol) was synthesized from [ 14 C]-testosterone. A biological assay was developed to measure the oxidation of [ 14 C]-3α-diol in cells. Inhibitors of dihydrotestosterone (DHT) formation from 3α-diol were identified. DHT formation via non-classic pathways was inhibited in prostate cancer LAPC-4 cells. Abstract: 5α-Dihydrotestosterone (5α-DHT) possesses a great affinity for the androgen receptor (AR), and its binding to AR promotes the proliferation of prostate cancer (PC) cells in androgen-dependent PC. Primarily synthesized from testosterone (T) in testis, 5α-DHT could also be produced from 5α-androstane-3α, 17β-diol (3α-diol), an almost inactive androgen, following non-classical pathways. We reported the chemical synthesis of non-commercially available [4- 14 C]-3α-diol from [4- 14 C]-T, and the development of a biological assay to identify inhibitors of the 5α-DHT formation from radiolabeled 3α-diol in LAPC-4 cell PC model. We measured the inhibitory potency of 5α-androstane derivatives against the formation of 5α-DHT, and inhibition curves were obtained for the most potent compounds (IC50 = 1.2–14.1 μM). The most potent inhibitor 25 (IC50 = 1.2 μM) possesses a 4-(4-CF3 -3-CH3 O-benzyl)piperazinyl methyl side chain at C3β and 17β-OH/17α-CCH functionalities at C17 of a 5α-androstane core.
- Is Part Of:
- Bioorganic & medicinal chemistry letters. Volume 30:Issue 2(2020)
- Journal:
- Bioorganic & medicinal chemistry letters
- Issue:
- Volume 30:Issue 2(2020)
- Issue Display:
- Volume 30, Issue 2 (2020)
- Year:
- 2020
- Volume:
- 30
- Issue:
- 2
- Issue Sort Value:
- 2020-0030-0002-0000
- Page Start:
- Page End:
- Publication Date:
- 2020-01-15
- Subjects:
- Steroid -- Prostate cancer -- LAPC-4 cells -- Androstane derivative -- Androgen
Bioorganic chemistry -- Periodicals
Pharmaceutical chemistry -- Periodicals
572 - Journal URLs:
- http://www.elsevier.com/wps/find/journaldescription.cws_home/972/description#description ↗
http://www.sciencedirect.com/science/journal/0960894X ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.bmcl.2019.126783 ↗
- Languages:
- English
- ISSNs:
- 0960-894X
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 2089.330000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 22552.xml